BRAF and nasopharyngeal carcinoma: Additionally, TINCR can interact with ATP-Citrate Lyase (ACLY), BRAF, and Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1) in nasopharyngeal cancer, non-small cell lung cancer, and post-burn skin fibroblasts, respectively [30–32].